Intestinal Disease Articles & Analysis
5 news found
With locations in the US and Europe, today MatTek's offerings include skin, eye, oral, respiratory, vaginal, and intestinal tissue models including disease modeling, validated, and custom testing services, multiple donor primary cells, culture media, and highly optical cultureware. ...
In recent years, the analysis of viral nucleic acid sequences in the intestine by high-throughput sequencing technology has revealed a dynamic and diverse enterovirome. ...
The study synthesizes multiple streams of existing evidence from molecular biology through clinical observations to build a new paradigm for understanding the role of the small intestine in metabolic disease. The company believes the Metabolic Balance Model is one of the most comprehensive frameworks in this field. ...
It will evaluate the efficacy of Revita DMR (duodenal mucosal resurfacing), a first-in-class intervention targeting the role of the intestine in metabolic disease. The trial’s primary endpoint is the percentage of patients who are able to achieve target glycemic control (HbA1c less than or equal to 7%) without the need for insulin at 24 weeks, comparing ...
Spore crops grown using the test method (soon to be published as E3011, Test Method for in vitro Production of Clostridium Difficile Spores) will be used in laboratories to test the efficacy of drugs that fight C. difficile, a source of infectious intestinal diseases such as colitis. Subcommittee E35.15 on Antimicrobial Agents invites all interested parties to ...